Cargando…
Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020747/ http://dx.doi.org/10.1007/s40265-023-01850-3 |
| _version_ | 1784908333158760448 |
|---|---|
| author | Tong, Qiang Wang, Shiow-Ing Wei, James Cheng-Chung Dai, Sheng-Ming |
| author_facet | Tong, Qiang Wang, Shiow-Ing Wei, James Cheng-Chung Dai, Sheng-Ming |
| author_sort | Tong, Qiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10020747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100207472023-03-17 Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” Tong, Qiang Wang, Shiow-Ing Wei, James Cheng-Chung Dai, Sheng-Ming Drugs Letter to the Editor Springer International Publishing 2023-03-17 2023 /pmc/articles/PMC10020747/ http://dx.doi.org/10.1007/s40265-023-01850-3 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Tong, Qiang Wang, Shiow-Ing Wei, James Cheng-Chung Dai, Sheng-Ming Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title | Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title_full | Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title_fullStr | Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title_full_unstemmed | Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title_short | Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study” |
| title_sort | authors’ reply to huang and zhang: comment on “risk of erectile dysfunction in male patients with gout treated with febuxostat or allopurinol: a propensity score-matched cohort study” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020747/ http://dx.doi.org/10.1007/s40265-023-01850-3 |
| work_keys_str_mv | AT tongqiang authorsreplytohuangandzhangcommentonriskoferectiledysfunctioninmalepatientswithgouttreatedwithfebuxostatorallopurinolapropensityscorematchedcohortstudy AT wangshiowing authorsreplytohuangandzhangcommentonriskoferectiledysfunctioninmalepatientswithgouttreatedwithfebuxostatorallopurinolapropensityscorematchedcohortstudy AT weijameschengchung authorsreplytohuangandzhangcommentonriskoferectiledysfunctioninmalepatientswithgouttreatedwithfebuxostatorallopurinolapropensityscorematchedcohortstudy AT daishengming authorsreplytohuangandzhangcommentonriskoferectiledysfunctioninmalepatientswithgouttreatedwithfebuxostatorallopurinolapropensityscorematchedcohortstudy |